To examine the role of heme oxygenase (HO)-1 in the pathophysiology of vascular diseases, we generated mice deficient in both HO-1 and apolipoprotein E (HO-1 -/-apoE -/-). Despite similar total plasma cholesterol levels in response to hypercholesterolemia, HO-1 -/-apoE -/-mice, in comparison with HO-1 +/+ apoE -/-mice, had an accelerated and more advanced atherosclerotic lesion formation. In addition to greater lipid accumulation, these advanced lesions from HO-1 -/-apoE -/-mice contained macrophages and smooth muscle α-actin-positive cells. We further tested the role of HO-1 on neointimal formation in a mouse model of vein graft stenosis. Autologous vein grafts in HO-1 -/-mice showed robust neointima consisting of α-actin-positive vascular smooth muscle cells (VSMC) 10 days after surgery in comparison to the smaller neointima formed in autologous vein grafts in HO-1 +/+ mice. However, at 14 days after surgery, the neointima from composite vessels of HO-1 -/-mice was composed mainly of acellular material, indicative of substantial VSMC death. VSMC isolated from HO-1 -/-mice were susceptible to oxidant stress, leading to cell death. Our data demonstrate that HO-1 plays an essential protective role in the pathophysiology of atherosclerosis and vein graft stenosis.
H progression of vascular diseases such as atherosclerosis, which is initiated and propagated by inflammation and oxidative stress (10, 11) .
Atherosclerosis is initiated by injury to the arterial wall (10, 11) . In individuals with hypercholesterolemia, low-density lipoproteins (LDL) and their oxidized forms are a critical source of injury, leading to an inflammatory response. As the atherosclerotic lesion progresses, migration and proliferation of smooth muscle cells (SMC) and deposition of fibrous tissue lead to advanced, complicated lesions (10, 11) . HO-1 is known to be up-regulated by oxidized LDL (12) , and previous studies have shown that HO-1 is expressed in atherosclerotic lesions of humans and apolipoprotein (apo) E-deficient mice (13) . Moreover, recent studies suggest that overexpression of HO-1, using gene transfer techniques, reduces vasoconstriction, inhibits cell proliferation following vascular injury (14) , and inhibits the development of atherosclerotic lesions in apoE-deficient mice (15) . These overexpression experiments suggest a therapeutic role for HO-1 in atherosclerosis. However, the role of endogenous HO-1 in modulating atherosclerotic lesion formation has not yet been defined.
Obstructive atherosclerotic lesions lead to coronary artery disease in patients. While coronary artery stenting is increasingly being used to treat these patients, stenting is associated with a greater need for repeated procedures in comparison with coronary artery bypass graft surgery (CABG) (16) . Therefore, CABG remains an important treatment for multivessel disease (16, 17) . The use of arterial conduits has improved the outcome of CABG, yet autologous vein grafts provide an important and convenient conduit for bypass graft surgery (18, 19) . Whereas early grafts occlude due to thrombotic events, later onset of vein graft occlusion occurs due to intimal thickening and superimposed atherosclerosis (20) . The role of HO-1 in this process of vein graft disease remains unknown.
Thus, the goals of the present study are to investigate the importance of HO-1 in the pathophysiology of hypercholesterolemia-induced atherosclerosis and to determine the role of HO-1 in vein graft disease, using a murine model of vein graft stenosis.
MATERIALS AND METHODS

Generation of mice deficient in both HO-1 and apoE
To generate mice deficient in both HO-1 and apoE (HO-1 -/-apoE -/-), HO-1 heterozygous mice of 129Sv and C57BL/6J mixed genetic background (21) were backcrossed 10 generations, fixed on a C57BL/6J background, and then bred with apoE -/-mice (C57BL/6J-apoe tm1Unc , Jackson Laboratories, Bar Harbor, ME). The mice were genotyped by Southern blot analysis (21, 22) . All animal experiments were performed in accordance with National Institutes of Health guidelines, and protocols were approved by the Harvard Medical Area Standing Committee on Animals.
Hypercholesterolemic mouse model
Starting at 4 wk of age, female mice were placed on a Western diet containing 1.25% cholesterol and 21% fat (TestDiet). After 8 wk on the Western diet, we determined plasma total cholesterol levels with a commercially available kit (Roche, Indianapolis, IN The vasculature was perfused from the left ventricle with phosphate-buffered saline, and the aortic arch and its branches (including the right brachiocephalic artery, the right and left common carotid arteries, and the right and left subclavian arteries) were dissected. For lipid staining, the vessels were dissected out, pinned on silicone, postfixed with formalin, and stained with Sudan IV as previously described (22) . To further assess lesion burden, we analyzed the arch of the aorta and its arterial branches in a subgroup of animals (n=3) by using the light microscopy images. Computerized planimetry was used to quantitate the area occupied by atherosclerotic lesions in the aortic arch and its branches. A percentage of vessel area occupied by atherosclerotic lesions was calculated, dividing lesion area by the entire area of the vessels and multiplying by 100. For histological analysis, the vessels were dissected out and fixed in methyl Carnoy's solution at 4°C for 3 h and then in 70% ethanol overnight and embedded in paraffin (22) . Lesions in apoE -/-mice appeared principally at branch points, the lesser curvature of aortic arch, or at bifurcations of aorta (23) . We examined lesion formation at the most proximal portion of the brachiocephalic artery as previously described (22) . We started to collect 5-µm sections when the first complete brachiocephalic arterial ring appeared. Three sets of four consecutive sections obtained from the start of brachiocephalic artery (each set obtained at 125-µm intervals) were used for morphometry (22) .
Mouse model of vein graft stenosis
Eight-to 12-wk-old male wild-type (n=9) and HO-1 -/-(n=7) littermates (21) (background of 129Sv and BALB/c, 50% in both strains) were subjected to a mouse model of vein graft stenosis (24) . Because genetic background does not affect vein graft stenosis (24) and because there is a high prenatal/perinatal lethality of pure background HO-1 -/-mice, we used mixed background mice for this study. In brief, a segment of jugular vein patch (∼5 mm long) was transected from the main trunk, and a longitudinal defect (about the same length as the jugular vein patch) was created in the carotid artery. The autogenous jugular vein patch was then sutured into the carotid artery defect around the margin of the patch. The grafts, together with a short segment of the native carotid artery were harvested 10 or 14 days after surgery as previously described (24) . The specimens were cut at the center of the graft and fixed in methyl Carnoy's solution, processed, and embedded in paraffin. Consecutive serial sections (5 µm) were cut from the center of the graft to the proximal and distal ends at the junction with the native carotid artery.
Histological analysis and immunohistochemistry
Sectioned vessels from hypercholesterolemic mice or from composite vein grafts were stained with Verhoeff's stain for elastin and subjected to quantitative morphological analysis as previously described (22, 24) . The intima area (defined as the region between internal elastic lamina and the lumen) and the area inside the internal elastic lamina were measured by using NIH Image software. The percentage luminal occlusion was calculated as intima area divided by the area inside the internal elastic lamina and multiplied by 100. Data are presented as mean ±SE. Overall comparison between groups was performed with the Student's t test. Statistical significance was accepted at P<0.05.
To detect HO-1 expression, we stained sections with a polyclonal anti-HO-1 antiserum (SPA-895, diluted 1:400; StressGen Biotechnologies, Victoria, BC, Canada). Sections were stained with a macrophage-specific anti-mouse MOMA-2 antibody (diluted 1:50, Serotec, Kidlington, Oxford, UK) and a smooth muscle (SM) α-actin antibody (diluted 1:50, Sigma, St. Louis, MO), respectively. To detect calcium deposition, we performed von Kossa staining on vein graft vessels.
Mouse primary VSMC culture
Mouse aortic smooth muscle cells (MASMC) from wild-type and HO-1 -/-mice (8-to 12-wkold) were isolated and cultured according to the method of Günther et al. (25) , with modifications (26).
Hydrogen peroxide-induced cytotoxicity
Wild-type and HO-1 -/-MASMC were plated on 96-well plates at a density of 5000 cells/well in phenol red-free media (Invitrogen Life Technologies, Carlsbad, CA) and allowed to attach overnight. Cells were treated with different concentrations of freshly diluted hydrogen peroxide (Sigma). Cell viability was determined using a MTT kit (Roche).
RESULTS
Increased atherosclerotic lesion formation in HO-
1 -/- apoE -/- mice
ApoE
-/-mice (27, 28) have been widely used as a hypercholesterolemic animal model to investigate the atherogenic processes. Thus, to examine the role of HO-1 in the development of atherosclerosis, we generated mice deficient in both HO-1 and apoE. To assess lesion formation, female HO-1 1C and 1D , red). To further assess lesion burden, in a subgroup of animals the arch of the aorta and its arterial branches (including the brachiocephalic, right subclavian, right common carotid, left subclavian, and left common carotid arteries) were analyzed for atherosclerotic lesion formation. In the HO-1 +/+ apoE -/-mice, 5.3±0.7% of the aortic arch and its branches were occupied by lesions. However, the HO-1 -/-apoE -/-mice had 19 .5±0.69% of the aortic arch and its branches covered by lesions (P<0.001, n=3 in each group).
Lesions in apoE -/-mice appeared principally at branch points and the lesser curvature of aortic arch or at bifurcations of aorta (23) . We examined lesion formation at the most proximal branch of brachiocephalic artery as described (22) . Verhoeff's elastin staining ( Fig. 2A and 2B (Fig. 2C, brown) . In contrast, the lesions from HO-1 -/-apoE -/-mice were not only more occlusive but also more advanced, with increased accumulation of macrophages (Fig. 2D, brown) , which appeared to be lipid-filled foam cells (Fig. 2B, arrows) . In HO-1 +/+ apoE -/-mice, SM α-actin-positive cells were present only in the medial SM layers of the arteries, but not in the lesions (Fig. 2E) . After 8 wk on the Western diet, SMC-the hallmark of advanced lesions-were present in the HO-1 -/-apoE -/-mouse lesions (Fig. 2F , arrow). The HO-1 +/+ apoE -/-mice had less advanced lesions that did not contain a fibrous cap (Fig. 2G, arrowhead) , in contrast to SMC-rich fibrous caps in the lesions from HO-1 -/-apoE -/-mice ( Fig. 2H, arrow) .
HO-1 induction in the vein graft neointima
Autologous vein graft bypass surgery provides an important treatment for occlusive arterial lesions (18, 19) . To investigate the role of HO-1 in vein graft stenosis, wild-type and HO-1 -/-mice were subjected to a mouse model of vein graft stenosis (24) . This model is characterized by the rapid development in the grafted venous tissue of a neointima consisting largely of SM α-actin-positive cells (24) .
We first examined the expression of HO-1 in carotid arteries and jugular veins from wild-type mice. Immunostaining with HO-1 antibody revealed that HO-1 expression was detectable in the medial SM layers of the native carotid arteries but not in jugular veins (data not shown). Ten days after surgery, in response to hemodynamic stress, neointima formation in the vein graft of composite vessels was evident (Fig. 3A) . In addition, we detected HO-1 expression in the neointima of vein graft (Fig. 3B) . Fourteen days after surgery, there was a robust formation of neointima in the vein graft (Fig. 3C) . Interestingly, HO-1 was expressed in the majority of neointimal cells (Fig. 3D) .
Increased neointima formation in HO-1 -/-mice 10 days after surgery
Given that HO-1 is induced in the neointima of the vein grafts, we hypothesized that HO-1 may play a role in the adaptation of VSMC to hemodynamic stress in vascular wall remodeling. Ten days after surgery, in contrast to the minimal neointimal formation in wild-type mice ( Fig. 4A; 13.3±2.5% luminal occlusion, n=5), there was a robust neointima formation in HO-1 -/-mice ( Fig. 4B; 34 .2±8.7% luminal occlusion, n=4; P<0.05 vs. wild-type). In wild-type composite vessels, SM α-actin-positive cells were detected mainly in the medial SM layers of the arterial portion and the small population of neointimal cells (Fig. 4C) . In HO-1 -/-composite vessels, however, both arterial medial SM layers and the large vein graft neointima stained positive for SM α-actin, indicating that the neointima was consisted primarily of VSMC (Fig. 4D) .
VSMC death and calcification in HO-1 -/-vein grafts
Fourteen days after surgery, in composite vessels from wild-type (HO-1 +/+ ) mice, there was robust formation of neointima ( Fig. 5A; 45.6±3.9% luminal occlusion, n=4) . In comparison, 62.6±6.6% of the lumen was occluded in HO-1 -/-composite vessels (Fig. 5B, n=3) . At a higher magnification, robust neointimal cells were present between the lumen and internal elastic lamina in wild-type vein grafts (Fig. 5C ) as opposed to acellular material in HO-1 -/-vein grafts (Fig. 5D) . Vein graft neointima from wild-type composite vessels consisted of α-actin-positive VSMC (Fig. 5E ). Very few SM α-actin-positive VSMC were detected in the neointima of HO-1 -/-vein grafts (Fig. 5F ), indicating death of VSMC. We began to observe circumferentially oriented elastic laminae in wild-type vein grafts (Fig. 5G, arrowheads) , indicating arterialization of the graft. Consistent with the initial report describing the vein graft stenosis model (24), we only observed progressive arterialization but no cell loss in the wildtype littermate controls at later stages (21 and 28 days, data not shown). In the HO-1 -/-neointima, we observed closely layered elastic laminae toward the lumen (Fig. 5H,  arrowheads) , one of the characteristics of advanced lesions (29) . Vascular calcification has been observed in vein grafts of animal models (30, 31) and late human vein grafts (32, 33) . To determine whether calcium deposits were present in the neointima of vein grafts, we performed von Kossa staining on composite vessel sections. Only a few cells from wild-type neointima stained positive (Fig. 5I, brown) , indicating calcium deposition in limited neointimal cells. In contrast, von Kossa staining revealed that the acellular material in the neointima from HO-1 -/-mice stained strongly for the deposition of calcium (Fig. 5J, brown) . These data are consistent with dystrophic calcification, extracellular calcium deposition, in areas of cell death.
VSMC from HO-1 -/-mice are more susceptible to oxidative stress
To elucidate the potential molecular mechanism leading to VSMC death, we isolated aortic SMC from wild-type and HO-1 -/-mice and treated the cells with hydrogen peroxide (H 2 O 2 ). Both wild-type and HO-1 -/-VSMC tolerated H 2 O 2 concentrations up to 800 µM, with only a slight decrease in viability (Fig. 6) . With an additional small increase (50 µM) in concentration to 850 µM, 80% of wild-type VSMC were still viable. In comparison, the viability of HO-1 -/-VSMC decreased to <10% (Fig. 6) . At concentrations >900 µM, almost no viability was detected in HO-1 -/-VSMC whereas ∼60-70% of wild-type cells survived (Fig. 6 ). These data suggested that HO-1 -/-VSMC were more susceptible to oxidant H 2 O 2 -induced cell death in comparison with VSMC isolated from wild-type mice.
DISCUSSION
Oxidative stress and inflammation contribute to hypercholesterolemia-induced atherosclerosis (11, 34) . Consistent with this concept, it was recently reported that an anti-inflammatory drug (aspirin) has anti-atherogenic effects by suppressing vascular inflammation in LDL-receptor knockout mice (35) . HO-1 and its reaction product CO have been shown to have antioxidative and anti-inflammatory properties (4, 36, 37) . Furthermore, induction of HO-1 occurs in atherosclerotic lesions (13, 38, 39) , suggesting this induction may serve to slow the progression or limit the extent of atherosclerosis. Thus, in the present study, we tested the hypothesis that absence of HO-1 may promote inflammation and exacerbate atherosclerotic lesion formation.
In response to hypercholesterolemia, mice deficient in both HO-1 and apoE developed larger and more advanced lesions than mice deficient in apoE alone. Consistent with our findings, LDL-receptor knockout mice treated with an inhibitor of heme oxygenase activity (Snprotoporphyrin IX) have enhanced atherosclerotic lesion formation when fed a high-fat diet (39) . However, metalloporphyrins inhibit all HO isoforms (40) . Thus, it is difficult to assess which isoform is responsible for the effect in this previous study. Our results clearly show that the loss of HO-1 alone is sufficient to accelerate atherosclerosis and indicate that the activities of other isoforms do not fully compensate for the loss of HO-1. Although the mechanisms by which HO-1 exerts its role on atherogenesis are not fully understood, the enhanced infiltration of monocytes into the arterial wall in the absence of HO-1 may contribute to the exacerbation of lesion formation. Supporting this hypothesis, endothelial and SMC coculture experiments have shown that HO-1 inhibits the monocyte transmigration induced by mildly oxidized LDL (12) .
In addition to its anti-inflammatory role mediated through CO (4), HO-1 maintains iron homeostasis (41) . Interestingly, iron deposition is associated with the progression of atherosclerosis in apoE -/-mice (42) . Furthermore, overexpression of HO-1 via adenovirusmediated gene transfer inhibits the development of atherosclerotic lesions in arterial wall by facilitating iron metabolism (15) . Thus, the excessive iron accumulation resulting from the absence of HO-1 (41) may exacerbate lesion formation. Investigators have also suggested that a mild increase in bilirubin, one of the reaction products of heme metabolism by HO-1, reduces the risk of atherosclerosis (43) (44) (45) . Therefore, decreased bilirubin levels in the absence of HO-1 may lead to increased lesion formation. It is likely that HO-1 regulates atherogenesis through the concerted effects of CO, iron, and bilirubin.
To examine the effects of the loss of HO-1 activity on vascular remodeling in a different form of obstructive vascular disease, we used a mouse jugular vein/carotid artery autograft model to mimic the vein grafts used in bypass surgery. Despite the persistent problem of vein graft stenosis, which leads to graft failure in a significant percentage of patients (18, 19) , the use of autologous vein grafts during coronary artery bypass surgery remains an important therapeutic intervention for patients with coronary artery disease. Given our findings with the hyperlipidemic mouse model of atherosclerosis, we hypothesized that the absence of HO-1 activity might also affect the development of vein graft disease. Our results demonstrate that endogenously induced HO-1 plays a protective role in vein graft stenosis.
We observed no histological differences in blood vessels (data not shown) and no differences in systemic arterial pressure between wild-type and HO-1 -/-mice (46) . Therefore, vein grafts were exposed to similar arterial pressures in both wild-type and HO-1 -/-mice. However, in response to similar hemodynamic stress 10 days after surgery, HO-1 -/-mice had much larger neointima than wild-type mice (Fig. 4) . HO-1 and its product CO have been postulated to inhibit SMC proliferation (8, 14) . Thus, it is conceivable that absence of HO-1 and subsequent reduction of CO in HO-1 -/-mice resulted in increased SMC proliferation and neointima formation.
Surprisingly, instead of developing even larger lesions 14 days after surgery, there was massive cell death in the neointima of HO-1 -/-mice. Interestingly, we only observed TUNEL-positive cells in the neointima from HO-1 -/-but not from HO-1 +/+ mice (data not shown), suggesting that in addition to necrosis, apoptosis is one of the mechanisms leading to VSMC death in HO-1 -/-vein grafts. The VSMC death, together with calcification in areas of cell death (Fig. 5) , indicate an acceleration of vein graft disease (31, 32) in HO-1 -/-mice. Our data suggest that the vein graft had a maladaptive response to increased pressure in the absence of HO-1. This maladaptation to pressure overload leading to cell death is similar to what we observed in HO-1 -/-mice that developed severe right ventricular dilatation, oxidative stress, and infarction in response to pulmonary hypertension after exposure to chronic hypoxia (21) .
Increased hemodynamic pressure induces oxidative stress and HO-1 expression in VSMC (47, 48) , suggesting a protective role of HO-1 in the cell's defense against oxidative damage in the vasculature. Consistent with this hypothesis, VSMC from HO-1 -/-mice are more prone to oxidant-induced cell death (Fig. 6 ), indicating that susceptibility to oxidative stress is one of the mechanisms leading to cell death in the absence of HO-1. Interestingly, a patient deficient in HO-1 displayed enhanced sensitivity to oxidative stress (49) . Two recent studies associated human HO-1 gene promoter polymorphisms with risk for vascular diseases (50, 51) . It was suggested that a dinucleotide repeat (GT) in the promoter region of the HO-1 gene shows a length polymorphism that modulates the level of gene transcription. In both studies, individuals with longer dinucleotide repeats in the HO-1 gene promoter revealed atherosclerosis and coronary artery disease (50), or restenosis (51), significantly more often than patients with shorter dinucleotide repeats. These data imply that decreased expression of HO-1 promotes the development of vascular diseases, including atherosclerosis and restenosis.
We demonstrate in the present study by gene deletion experiments that HO-1 plays an essential, protective role in vascular remodeling in the settings of hypercholesterolemia and vein graft stenosis. These results, along with our previous findings in the heart (21, 36), as well as human studies (50, 51) , indicate that a decrease or absence of HO-1 exacerbates cardiovascular disease. , filled bars) and HO-1 -/-(white bars) aortic smooth muscle cells were plated on 96-well plates and treated with different concentrations of hydrogen peroxide. Cell viability was determined using an MTT kit. Cell survival is expressed relative to that without hydrogen peroxide treatment.
